Search results
Results From The WOW.Com Content Network
Roche inks a deal with Foundation Medicine to acquire the remaining shares of Foundation Medicine, not already owned by it for a total consideration of $2.4 billion.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Click here for in-depth analysis of the latest stock market news and events moving stock prices. Read the latest financial and business news from Yahoo Finance Show comments
Foundation Medicine was founded in Cambridge, Massachusetts. [3] The company was conceived after Broad Institute researchers Levi Garraway and Matthew Meyerson published a 2007 paper detailing a method for large-panel testing of 238 DNA mutations. [4] Foundation Medicine launched in 2010 with a $25 million Series A financing led by Third Rock ...
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Level 2 data displays the best bid and ask prices (also known as "top-of-book") for each market participant in a given security. In other words, at a given time there may be several market makers participating in trade matching for a specific stock. Level 2 data will display the highest bid and lowest ask for each individual market maker.
The initial public offering was June 21, 2000 at US$6 per share. Cepheid stock was listed on the Nasdaq under the ticker symbol CPHD until it was acquired by Danaher in 2016. [35] [independent source needed] The company's first CEO was Tom Gutshall, who held the position from 1996 to 2002. [36] In April 2002, John L. Bishop was appointed CEO. [2]
Foundation Medicine Prices Initial Public ... -- Foundation Medicine, Inc. today announced the pricing of its initial ... public offering of 5,888,888 shares of common stock at a price of ...